jueves, 30 de diciembre de 2010

Sindrome de Apert

Apert Syndrome

Author: Harold Chen, MD, MS, FAAP, FACMG, Professor, Departments of Pediatrics, Obstetrics and Gynecology, and Pathology, Director of Genetic Laboratory Services, Louisiana State University Medical Center
Contributor Information and Disclosures

Updated: Sep 2, 2009

advertisement
Information from Industry
Clinical studies in treating eczema with colloidal oatmeal- based skincare
Over-the-counter, colloidal oatmeal-based skincare regimen proven in 2 clinical studies in eczema.
Review clinical trial data

Introduction

Background

  • Apert syndrome is named for the French physician who described the syndrome acrocephalosyndactylia in 1906.
  • Apert syndrome is a rare autosomal dominant disorder characterized by craniosynostosis, craniofacial anomalies, and severe symmetrical syndactyly (cutaneous and bony fusion) of the hands and feet.

  • An infant with Apert syndrome is shown. Note the ...

    An infant with Apert syndrome is shown. Note the characteristic ocular hypertelorism, down-slanting palpebral fissures, proptotic eyes, horizontal groove above the supraorbital ridge, break of the continuity of eyebrows, depressed nasal bridge, and short wide nose with bulbous tip.

    An infant with Apert syndrome is shown. Note the ...

    An infant with Apert syndrome is shown. Note the characteristic ocular hypertelorism, down-slanting palpebral fissures, proptotic eyes, horizontal groove above the supraorbital ridge, break of the continuity of eyebrows, depressed nasal bridge, and short wide nose with bulbous tip.


  • Note the mitten appearance of the hands with synd...

    Note the mitten appearance of the hands with syndactyly involving the second, third, fourth, and fifth fingers. This patient also has characteristic concave palms, hitchhiker posture (radial deviation) of short broad thumbs, and contiguous nailbeds (synonychia).

    Note the mitten appearance of the hands with synd...

    Note the mitten appearance of the hands with syndactyly involving the second, third, fourth, and fifth fingers. This patient also has characteristic concave palms, hitchhiker posture (radial deviation) of short broad thumbs, and contiguous nailbeds (synonychia).


  • Note the sock appearance of the feet with syndact...

    Note the sock appearance of the feet with syndactyly involving the second, third, fourth, and fifth toes. The patient also has contiguous nail beds (synonychia).

    Note the sock appearance of the feet with syndact...

    Note the sock appearance of the feet with syndactyly involving the second, third, fourth, and fifth toes. The patient also has contiguous nail beds (synonychia).


  • In this profile, turribrachycephaly, high promine...

    In this profile, turribrachycephaly, high prominent forehead, proptosis, depressed nasal bridge, short nose, and low-set ears are prominent.

    In this profile, turribrachycephaly, high promine...

    In this profile, turribrachycephaly, high prominent forehead, proptosis, depressed nasal bridge, short nose, and low-set ears are prominent.


  • This radiograph demonstrates turribrachycephaly, ...

    This radiograph demonstrates turribrachycephaly, shallow orbits, ocular hypertelorism, and hypoplastic maxilla.

    This radiograph demonstrates turribrachycephaly, ...

    This radiograph demonstrates turribrachycephaly, shallow orbits, ocular hypertelorism, and hypoplastic maxilla.


  • Note osseous syndactyly involving the second, thi...

    Note osseous syndactyly involving the second, third, fourth, and fifth fingers; multiple synostosis involving distal phalanges and proximal fourth and fifth metacarpals; symphalangism of interphalangeal joints; shortening and radial deviation of distal phalanx; and delta-shaped deformity of proximal phalanx of the thumbs.

    Note osseous syndactyly involving the second, thi...

    Note osseous syndactyly involving the second, third, fourth, and fifth fingers; multiple synostosis involving distal phalanges and proximal fourth and fifth metacarpals; symphalangism of interphalangeal joints; shortening and radial deviation of distal phalanx; and delta-shaped deformity of proximal phalanx of the thumbs.


  • Note osseous syndactyly, fusion of interphalangea...

    Note osseous syndactyly, fusion of interphalangeal joints, synostosis involving proximal first and second metatarsals, and partially duplicated and delta-shaped proximal phalanx of the great toes.

    Note osseous syndactyly, fusion of interphalangea...

    Note osseous syndactyly, fusion of interphalangeal joints, synostosis involving proximal first and second metatarsals, and partially duplicated and delta-shaped proximal phalanx of the great toes.

  • It is probably the most familiar and best-described type of acrocephalosyndactyly.
  • Reproductive fitness is low, and more than 98% of cases arise by new mutation.

Pathophysiology

  • During early infancy (<3 mo), the coronal suture area is prematurely closed. A bony condensation line beginning at the cranial base and extending upward with a characteristic posterior convexity represents this occurrence. Anterior and posterior fontanelles are widely patent. The midline of the calvaria has a gaping defect, extending from the glabellar area to the posterior fontanelle via the metopic suture area, anterior fontanelle, and sagittal suture area. The skull with a gaping midline defect appears to permit adequate accommodation of the growing brain. The lambdoidal sutures appear normal in all cases.
  • During the first 2-4 years of life, the midline defect is obliterated by coalescence of the enlarging bony islands without evidence of any proper formation of sutures. An extreme short squama and orbital part of the frontal bone together with the posterior convexity of the coronal bone condensation line suggest that growth inhibition in the sphenofrontal and coronal suture area has its onset very early in fetal life.
  • Unique fibroblast growth factor receptor 2 (FGFR2) mutations lead to an increase in the number of precursor cells that enter the osteogenic pathway. Ultimately, this leads to increased subperiosteal bone matrix formation and premature calvaria ossification during fetal development. The order and rate of suture fusion determine the degree of deformity and disability. Once a suture becomes fused, growth perpendicular to that suture becomes restricted, and the fused bones act as a single bony structure. Compensatory growth occurs at the remaining open sutures to allow continued brain growth; however, complex, multiple sutural synostosis frequently extends to premature fusion of the sutures at the base of the skull, causing midfacial hypoplasia, shallow orbits, a foreshortened nasal dorsum, maxillary hypoplasia, and occasional upper airway obstruction.
  • The first genetic evidence that syndactyly in Apert syndrome is a keratinocyte growth factor receptor (KGFR)-mediated effect was provided by the observation of the correlation between KGFR expression in fibroblasts and severity of syndactyly. Patients with Ser252Trp and those with Pro253Arg have different phenotypic expression. The syndactyly is more severe with Pro253Arg mutation for both hands and feet, whereas cleft palate is significantly more common with Ser252Trp mutation.1
  • Amblyopia and strabismus is more common in patients with the FGFR2 Ser252Trp mutation, and optic disc pallor is more frequent in patients with the FGFR2 Pro253Arg mutation.2  Patients with FGR2 Ser252Trp mutations have a significantly greater prevalence of visual impairment compared with patients with the FGFR2 Pro253Arg mutation.3,4

Frequency

United States

  • Prevalence is estimated at 1 in 65,000 (approximately 15.5 in 1,000,000) live births.5,6,7
  • Apert syndrome accounts for 4.5% of all cases of craniosynostosis.

Mortality/Morbidity

  • Most patients experience some degree of upper airway obstruction during infancy. Upper airway compromise due to reduction in nasopharynx size and choanal patency as well as lower airway compromise due to anomalies of the tracheal cartilage may be responsible for early death.
  • Sleep apnea syndrome is common. Upper airway compromise, consisting of obstructive sleep apnea and cor pulmonale, may result from small nasopharyngeal and oropharyngeal dimension in the Apert craniofacial configuration.
  • Patients are at risk for complications resulting from elevated intracranial pressure despite surgical attempts to increase cranial capacity in infancy.

Race

  • Asians have the highest prevalence (22.3 cases per million live births).
  • Hispanics have the lowest prevalence (7.6 cases per million live births).

Sex

  • Apert syndrome has no sex predilection.

Age

  • Apert syndrome is detected in the newborn period due to craniosynostosis and associated findings of syndactyly in the hands and feet.

Clinical

History

  • Family history is usually not significant because most cases of Apert syndrome are sporadic. A paternal age effect increases in fathers older than 50 years.
  • Headache and vomiting are signs of acute increased intracranial pressure, especially in cases of multiple suture involvement.
  • Stridor and sleep apnea indicate problems with the upper airway, resulting from craniosynostosis of sutures of the base of the skull.
  • Visual disturbance can result from corneal injury due to exposed conjunctivitis and keratitis.
  • Many patients exhibit mental retardation, although patients with normal intelligence have been reported.

Physical

  • Skull and face
    • Craniostenosis is present. Coronal sutures most commonly are involved, resulting in acrocephaly, brachycephaly, turribrachycephaly, flat occiput, and high prominent forehead.
    • Large late-closing fontanels are observed.
    • A gaping midline defect is present.
    • A rare cloverleaf skull anomaly is present in approximately 4% of infants.
    • Common facial features during infancy include horizontal grooves above the supraorbital ridges that disappear with age, a break in the continuity of the eyebrows, and a trapezoid-shaped mouth at rest.
    • A flattened, often asymmetric face is observed.
    • Maxillary hypoplasia with retruded midface is present.
  • Ears, eyes, nose, and mouth
    • Patients have apparent low-set ears with occasional conductive hearing loss and congenital fixation of stapedial footplate.
    • Eyes exhibit down-slanting palpebral fissures, hypertelorism, shallow orbits, proptosis, exophthalmos, strabismus, amblyopia, optic atrophy, and, rarely, luxation of the eye globes, keratoconus, ectopic lentis, congenital glaucoma, lack of pigment in the fundi with occasional papilledema, and preventable visual loss or blindness.
    • The nose has a markedly depressed nasal bridge. It is short and wide with a bulbous tip, parrot-beaked appearance, and choanal stenosis or atresia.
    • The mouth area has a prominent mandible, down-turned corners, high arched palate, bifid uvula, and cleft palate.
    • Orthodontic problems include crowded upper teeth, malocclusion, delayed dentition, ectopic eruption, shovel-shaped incisors, supernumerary teeth, V-shaped maxillary dental arch, bulging alveolar ridges, dentitio tarda, some impaction, partial eruption, idiopathic root resorption, transposition or other aberrations in the position of the tooth germs, and severe crowding.
  • Extremities and digits
    • The upper limbs are more severely affected than lower limbs. Coalition of distal phalanges and synonychia found in the hands is never present in the feet. The glenohumeral joint and proximal humerus are more severely affected than the pelvic girdle and femur. The elbow is much less severely involved than the proximal portion of the upper limb.
    • Syndactyly involves the hands and feet with partial-to-complete fusion of the digits, often involving second, third, and fourth digits. These are often termed mitten hands and sock feet. In severe cases, all digits are fused, with the palm deeply concave and cup-shaped and the sole supinated.
    • Hitchhiker posture or radial deviation of short or broad thumbs results from abnormal proximal phalanx.
    • Brachydactyly occurs.
    • Nailbeds are contiguous (synonychia).
    • Some patients have subacromial dimples and elbow dimples during infancy.
    • Mobility at the glenohumeral joint is limited with progressive limitation in abduction, forward flexion, and external rotation with growth.
    • Limited elbow mobility is common with decreased elbow extension, flexion, pronation, and supination.
    • Short humeri are a constant finding beyond infancy.
    • Limited genu valga is present in many cases.
  • CNS
    • Intelligence varies from normal to mental deficiency, although a significant number of patients are mentally retarded. Malformations of the CNS may be responsible for most cases.
    • Common CNS malformations include megalencephaly, agenesis of the corpus callosum, malformed limbic structures, variable ventriculomegaly, encephalocele, gyral abnormalities, hypoplastic cerebral white matter, pyramidal tract abnormalities, and heterotopic gray matter. Progressive hydrocephalus is uncommon.
    • Papilledema and optic atrophy with loss of vision may be present in cases of subtle increased intracranial pressure.
  • Other skeletal and cartilaginous segmentation defects
    • Congenital cervical spinal fusion (68%), especially C5-C6
    • Aplasia or ankylosis of shoulder, elbow, and hip joints
    • Tracheal cartilage anomalies
    • Rhizomelia
  • Skin
    • Hyperhidrosis (common)
    • Synonychia
    • Brittle nails
    • Acneiform lesions (frequent after adolescence)
    • Interruption of the eyebrows
    • Hypopigmentation
    • Hyperkeratosis in the plantar surface
    • Paronychial infections (more common in feet than hands and in patients who are institutionalized patients)
    • Excessive skin wrinkling of forehead
    • Skin dimples at knuckles, shoulders, and elbows
  • Cardiovascular (10%)
  • Genitourinary (9.6%)
    • Polycystic kidneys
    • Duplication of renal pelvis
    • Hydronephrosis
    • Stenosis of bladder neck
    • Bicornuate uterus
    • Vaginal atresia
    • Protuberant labia majora
    • Clitoromegaly
    • Cryptorchidism
  • GI (1.5%)
    • Pyloric stenosis
    • Esophageal atresia and tracheoesophageal fistula
    • Ectopic or imperforate anus
    • Partial biliary atresia with agenesis of gallbladder
  • Respiratory (1.5%)
    • Anomalous tracheal cartilage
    • Tracheoesophageal fistula
    • Pulmonary aplasia
    • Absent right middle lobe of lung
    • Absent interlobular lung fissures

Causes

  • More than 98% of cases with Apert syndrome are caused by specific missense substitution mutations, involving adjacent amino acids (ie, Ser252Trp, Ser252Phe, Pro253Arg) in the linker between the second and third extracellular immunoglobulin domains of FGFR2, which maps to chromosome bands 10q26. The remaining cases are due to Alu-element insertion mutations in or near exon 9 of FGFR2.
  • Most cases are sporadic, resulting from new mutations with a paternal age effect. The incidence of FGFR2 mutations increases exponentially with paternal age, probably due to an increase in the frequency of these mutations and a selective advantage in the male germ line.8,9
  • Most new mutations, estimated at 1 per 65,000 live births, imply that germline transversion rates at these 2 positions are currently the highest known in the human genome. The rarity of familial cases can be explained by reduced genetic fitness of individuals because of severe malformations and the presence of mental retardation in many cases.

More on Apert Syndrome

Overview: Apert Syndrome
Differential Diagnoses & Workup: Apert Syndrome
Treatment & Medication: Apert Syndrome
Follow-up: Apert Syndrome

Retiro del propoxifeno y sibutramina

Siguenos en:
 
Próximos Eventos
 
31 mar. 3rd World Congress of Total Intravenous Anaesthesia and Target Controlled Infusion
 
21- 24 sep. Pain in Europe VII. 7th Congress of the European Federation of IASP (Hamburg, Germany)
 
Ver lista completa
 
 

Registrate con nosotros
 
Conoce México
Tips de Turismo
Ligas
Anestesiología y Medicina del Dolor
 
FMCA

No:364-A                                Diciembre 30, 2010
 
Estimad@ Maximo Jesus Cuadros Chavez:
El retiro de la sibutramina y del propoxifeno sucedieron en 2010 en USA. Aunque propoxifeno no es un analgésico de gran utilidad en dolor moderado a severo, si es una droga que se utiliza con mucha frecuencia en nuestros enfermos, en especial en la medicina socializada. Nos pareció importante enviarle este comunicado de la FDA para su consideración, y que esté alerta en caso de que sus pacientes cursen con alteraciones del ritmo cardiaco.
Retiro del propoxifeno en Estados Unidos de Norteamérica
19 de noviembre 2010 - La FDA ha pedido que el propoxifeno, que se vende bajo las marcas Darvon y Darvocet por los productos farmacéuticos Xanodyne, se quite del mercado de los EE.UU.. La decisión también afectará a los fabricantes de genéricos y los fabricantes de productos que contienen propoxifeno. Los nuevos datos clínicos muestran que el fármaco pone a los pacientes en riesgo de anormalidades en el ritmo cardiaco puede ser grave o incluso mortal. Se estima que 10 millones de pacientes han utilizado estos productos.
En una conferencia de prensa de hoy, el Dr John Jenkins, director de la Oficina de Nuevos Medicamentos, dijo que los nuevos números con punta de la relación riesgo-beneficio contra la droga. "Por primera vez, ahora tenemos datos que muestran que la dosis estándar terapéutica de propoxifeno puede ser perjudicial para el corazón", dijo el Dr. Gerald Dal Pan, director de la Oficina de Vigilancia y Epidemiología.
La FDA aconseja a los profesionales de la salud dejar de prescribir propoxifeno. Los pacientes que están tomando el medicamento no debe frenar bruscamente la medicación sino que debe contactar con su médico tan pronto como sea posible para discutir el cambio a otro tratamiento del dolor. "Los usuarios de largo tiempo de la droga tienen que saber que estos cambios en la actividad eléctrica del corazón no son acumulativos", agregó el Dr. Dal Pan. "Una vez que los pacientes dejan de tomar propoxifeno, el riesgo desaparece."
El propoxifeno es un opioide normalmente se utiliza para tratar dolores leves a moderados. Fue aprobado por primera vez por la FDA en 1957. Se vende con receta médica bajo varios nombres solos o en combinación con acetaminofén. Desde 1978, la FDA ha recibido dos peticiones para eliminar propoxifeno del mercado.
En enero de 2009, un comité asesor de la FDA votó 14-12 en contra de la continua comercialización de propoxifeno. En ese momento, el Comité pidió información adicional acerca de los efectos cardiacos de la droga.
Retiro ya está en marcha en Europa. La retirada gradual de propoxifeno ya está en marcha en Europa. La Agencia Europea de Medicamentos ha tomado esa decisión en junio de 2009. La FDA ha considerado un retiro el año pasado, pero decidió en cambio que permita seguir comercializando con una nueva advertencia en caja de alerta pacientes y profesionales de la salud del riesgo de sobredosis mortal. La agencia también requiere Xanodyne para llevar a cabo un estudio de seguridad nuevas preguntas sobre la evaluación de los efectos de propoxifeno en el corazón.
Los resultados de este estudio, junto con nuevos datos epidemiológicos y los informes médico forense, se le solicite esta última medida reglamentaria.
En caso de que la FDA ha actuado antes? El Dr. Dal Pan, dijo a Medscape Medical News que los reguladores no se sentía que había pruebas suficientes antes de ahora. "La nueva información sobre los efectos de la actividad eléctrica del corazón fue la última pieza del rompecabezas", dijo. "Estos datos nuevos sobre el corazón alteran significativamente el perfil propoxifeno de riesgo-beneficio", agregó el Dr. Jenkins. "La eficacia del fármaco para reducir el dolor ya no es suficiente para compensar la droga graves riesgos cardiacos potenciales."


Atentamente

Anestesiología y Medicina del Dolor
www.anestesia-dolor.org

---------- Mensaje reenviado ----------
De: Máximo Cuadros <maximocuadros@yahoo.es>
Fecha: 30 de diciembre de 2010 15:10
Asunto: {emergencias_y_desastres} Retiro del propoxifeno
Para: interno_residente_medico_PERU@yahoogroups.com


miércoles, 29 de diciembre de 2010

cardiopatias congenitas del adulto


 

Artículo especial
¿Es necesario hoy día una consulta de cardiopatías congénitas del adulto?
Resumen
Los pacientes adultos con cardiopatías congénitas son una población relativamente nueva de pacientes y en continuo crecimiento con unas características que los hacen diferentes al resto. El cardiólogo de adultos no está familiarizado con esta patología y no se dispone de la infraestructura necesaria para cubrir sus necesidades como se lleva a cabo en la edad pediátrica. Es necesaria la creación de consultas específicas dirigidas a atender las necesidades asistenciales de este grupo de pacientes.

Cardiocore. 2010;45:174-6.
Palabras clave: Adultos con cardiopatías congénitas



__._,_.___

Disfunción cardiaca en niños

 

---- Mensaje reenviado ----
De: Victor Whizar-Lugo <vwhizar@anestesia-dolor.org>
Para: maximocuadros@yahoo.es
Enviado: mié,29 diciembre, 2010 14:21
Asunto: Disfunción cardiaca en niños

 Anunciate con Anestesia-Dolor

Anestesia y Medicina del Dolor
Siguenos en:
Find us on Facebook Follow us on Twitter
Próximos Eventos
  
siguenos en facebook
Registrate con nosotros
Registrate a nuestra lista 
Conoce México
Ligas
 

No:363                               

Diciembre 29, 2010
 Colores de Mexico

Estimad@ Maximo Jesus Cuadros Chavez:

Disfunción cardiaca en niños malnutridos

Myocardial dysfunction in malnourished children
Faddan NA, El Sayh KI, Shams H, Badrawy H.
Ann Pediatr Card [serial online] 2010 [cited 2010 Dec 16];3:113-8.
 
Background : Malnourished children suffer several alterations in body composition that could produce cardiac abnormalities. Aim : The aim of the present study was to detect the frequency of myocardial damage in malnourished children as shown by echocardiography and cardiac troponin T (cTnT) level. Methods : Forty-five malnourished infants and young children (mean±SD of age was 11.24 ±7.88 months) were matched with 25 apparently healthy controls (mean±SD of age was 10.78±6.29 months). Blood sample was taken for complete blood picture, liver and kidney function tests, serum sodium, potassium, calcium levels and cTnT. All the malnourished children were subjected to echocardiographic evaluation. Results : Malnourished children showed a significantly lower left ventricular (LV) mass than the control group. The LV systolic functions were significantly impaired in patients with severe malnutrition. The cTnT level was higher than the upper reference limits in 11 (24.44%) of the studied malnourished children and all of them had a severe degree of malnutrition. The cTnT level was significantly higher in patients with anemia, sepsis and electrolyte abnormalities and it correlated negatively with LV ejection fraction (EF). Six of the studied children with high cTnT levels (54.5%) died within 21 days of treatment while only one case (2.9%) with normal level of cTnT died within the same period. Conclusions: LV mass is reduced in malnourished children. Children with severe malnutrition have a significant decrease in LV systolic functions. Elevated cTnT levels in malnourished children has both diagnostic and prognostic significance for cardiomyocyte damage.

 

Enlace para leer el artículo completo:


 http://www.annalspc.com/text.asp?2010/3/2/113/74036

 

Insuficiencia cardiaca en pediatría. Plan de actuación en atención primaria

Dr. JM Galdeano Miranda, Dr. C. Romero Ibarra, Dr. O. Artaza Barrios.
S. de Cardiología Pediátrica. Servicio Cardiovascular
H. de Cruces. Barakaldo. H. Vírgen del Camino. Pamplona. H. Luis Calvo Mackenna. Santiago de Chile 


Introducción
Se define la Insuficiencia Cardíaca en Pediatría (ICP), como la incapacidad del corazón para mantener un gasto cardia-co o volumen minuto adecuado a los re-querimientos del organismo.
La insuficiencia cardiaca es en el niño la manifestación de una enfermedad grave, generalmente una cardiopatía congénita, que con frecuencia tiene un tratamiento eficaz. Esto hace de sumo interés que el pediatra esté familiarizado con sus manifestaciones clínicas y con su tratamiento para poder realizar un diagnóstico precoz y adoptar las medidas terapéuticas adecuadas.

 

Artículo completo en PDF

 

Soporte vital extracorpóreo en disfunción cardiaca pediátrica

Extracorporeal life support in pediatric cardiac dysfunction.
Coskun KO, Coskun ST, Popov AF, Hinz J, El-Arousy M, Schmitto JD, Kececioglu D, Koerfer R.
Department of Thoracic and Cardiovascular Surgery, University of Göttingen, Göttingen, Germany.
J Cardiothorac Surg. 2010 Nov 17;5:112.

Abstract
BACKGROUND: Low cardiac output (LCO) after corrective surgery remains a serious complication in pediatric congenital heart diseases (CHD). In the case of refractory LCO, extra corporeal life support (ECLS) extra corporeal membrane oxygenation (ECMO) or ventricle assist devices (VAD) is the final therapeutic option. In the present study we have reviewed the outcomes of pediatric patients after corrective surgery necessitating ECLS and compared outcomes with pediatric patients necessitating ECLS because of dilatated cardiomyopathy (DCM). METHODS: A retrospective single-centre cohort study was evaluated in pediatric patients, between 1991 and 2008, that required ECLS. A total of 48 patients received ECLS, of which 23 were male and 25 female. The indications for ECLS included CHD in 32 patients and DCM in 16 patients. RESULTS: The mean age was 1.2 ± 3.9 years for CHD patients and 10.4 ± 5.8 years for DCM patients. Twenty-six patients received ECMO and 22 patients received VAD. A total of 15 patients out of 48 survived, 8 were discharged after myocardial recovery and 7 were discharged after successful heart transplantation. The overall mortality in patients with extracorporeal life support was 68%. CONCLUSION: Although the use of ECLS shows a significantly high mortality rate it remains the ultimate chance for children. For better results, ECLS should be initiated in the operating room or shortly thereafter. Bridge to heart transplantation should be considered if there is no improvement in cardiac function to avoid irreversible multiorgan failure (MFO).


Artí­culo en PDF

Atentamente
Dr. Enrique Hernández-Cortes
Anestesiología y Medicina del Dolor


__._,_.___

Nuevos marcadores en el sındrome...



sábado, 25 de diciembre de 2010

¿Es necesario hoy día una...

Maximo Cuadros Chavez posted in cibermedicos.
Artículo especial ¿Es necesario hoy día una consulta de cardiopatías congénitas del adulto? Resumen Los pacientes adultos con cardiopatías congénitas son una población  relativamente nueva de pacientes y en continuo crecimiento con unas  características que los hacen diferentes al resto. El cardiólogo de adultos no  está familiarizado con esta patología y no se dispone de la infraestructura  necesaria para cubrir sus necesidades como se lleva a cabo en la edad  pediátrica. Es necesaria la creación de consultas específicas dirigidas a  atender las necesidades asistenciales de este grupo de pacientes.  Cardiocore. 2010;45:174-6. Palabras clave: Adultos con cardiopatías congénitas  pulse sobre visualizar documento http://www.facebook.com/l/ee256aMEdKEZFgPmlmA7W-MLQmw;www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13187928&pident_usuario=0&pcontactid=&pident_revista=298&ty=66&accion=L&origen=elsevier&web=www.elsevier.es&lan=es&fichero=298v45n04a13187928pdf001.pdf>  Atte. Dr.Máximo Cuadros Chávez Celular 99199698 – Movistar - rpm #800515  http://www.facebook.com/l/ee256Gy75-ph3fRyRmLQQES2vCg;es.groups.yahoo.com/group/interno_residente_medico_PERU/ http://www.facebook.com/l/ee256AAlfTaIWR3Xf4IS82MCt7A;es.groups.yahoo.com/group/SANFERNANDOPERU/ http://es-la.facebook.com/people/Maximo-Cuadros-Chavez/100001101314342 http://www.facebook.com/group.php?gid=118221131544173 http://www.facebook.com/home.php?sk=group_150017968368005&ap=1 http://www.facebook.com/l/ee2565ObGDhiSNfFkGJDplHF13A;medicalia.ning.com/ UNYK: 245 HRP
Maximo Cuadros Chavez 12:17am Dec 24
Artículo especial
¿Es necesario hoy día una consulta de cardiopatías congénitas del adulto?
Resumen
Los pacientes adultos con cardiopatías congénitas son una población
relativamente nueva de pacientes y en continuo crecimiento con unas
características que los hacen diferentes al resto. El cardiólogo de adultos no
está familiarizado con esta patología y no se dispone de la infraestructura
necesaria para cubrir sus necesidades como se lleva a cabo en la edad
pediátrica. Es necesaria la creación de consultas específicas dirigidas a
atender las necesidades asistenciales de este grupo de pacientes.

Cardiocore. 2010;45:174-6.
Palabras clave: Adultos con cardiopatías congénitas

pulse sobre visualizar documento
http://www.facebook.com/l/ee256aMEdKEZFgPmlmA7W-MLQmw;www.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13187928&pident_usuario=0&pcontactid&pident_revista=298&ty=66&accion=L&origen=elsevier&web=www.elsevier.es&lan=es&fichero=298v45n04a13187928pdf001.pdf>

Atte.
Dr.Máximo Cuadros Chávez
Celular 99199698 – Movistar - rpm #800515

http://www.facebook.com/l/ee256Gy75-ph3fRyRmLQQES2vCg;es.groups.yahoo.com/group/interno_residente_medico_PERU/
http://www.facebook.com/l/ee256AAlfTaIWR3Xf4IS82MCt7A;es.groups.yahoo.com/group/SANFERNANDOPERU/
http://es-la.facebook.com/people/Maximo-Cuadros-Chavez/100001101314342
http://www.facebook.com/group.php?gid=118221131544173
http://www.facebook.com/home.php?sk=group_150017968368005&ap=1
http://www.facebook.com/l/ee2565ObGDhiSNfFkGJDplHF13A;medicalia.ning.com/
UNYK: 245 HRP

View Post on Facebook · Edit Email Settings · Reply to this email to add a comment.

sábado, 4 de diciembre de 2010

CARDIOLOGIA


 


     VII CURSO INTERNACIONAL TEÓRICO-PRÁCTICO DE TERAPIA ENDOVASCULAR & MIOCÁRDICA. MADRID 2009


http://www.revespcardiol.org/cardio/ctl_servlet?_f=7&ident=13009633


Introducción
Eulogio García Fernández.  Andrés Iñiguez Romo.  Carlos Macaya Miguel.  Antonio Serra Peñaranda. 
Rev Esp Cardiol.2010; 10(Supl.C) :1

Texto completo || PDF

Novedades en stents farmacoactivos. Actualización y futuros desarrollo
Antonio Serra Peñaranda.  Faustino Miranda Guardiola.  Beatriz Vaquerizo Montilla. 
Rev Esp Cardiol.2010; 10(Supl.C) :2-11

Resumen || Texto completo || PDF

Tratamiento de reperfusión en el infarto agudo de miocardio con elevación del segmento ST
Jose Antonio Baz.  Andrés Iñiguez Romo.  Eulogio García Fernández.  Antonio Serra Peñaranda.  Carlos Macaya Miguel. 
Rev Esp Cardiol.2010; 10(Supl.C) :12-20

Resumen || Texto completo || PDF

Nuevas evidencias y directrices en antiagregación y anticoagulación en síndrome coronario agudo e intervencionismo coronario percutáneo
David Vivas.  Antonio Fernández-Ortiz.  Carlos Macaya Miguel.  Eulogio García Fernández.  Andrés Iñiguez Romo.  Antonio Serra Peñaranda. 
Rev Esp Cardiol.2010; 10(Supl.C) :21-9

Resumen || Texto completo || PDF

Implantación transcatéter de prótesis valvular aórtica (situación actual, novedades tecnológicas y perspectivas clínicas). Resultados del Registro Edwards de implantación transfemoral en España
Eulogio García Fernández.  Rosana Hernández.  Carlos Macaya Miguel.  Andrés Iñiguez Romo.  Antonio Serra Peñaranda. 
Rev Esp Cardiol.2010; 10(Supl.C) :30-9

Resumen || Texto completo || PDF

Abstracts

Rev Esp Cardiol.2010; 10(Supl.C) :40-66

Texto completo || PDF

 


__._,_.___

Miocarditis Viral.ppt


 

He compartido Miocarditis Viral.ppt
Haz clic para abrir:
Google Docs facilita la creación, el almacenamiento y el uso compartido de hojas de cálculo, presentaciones y documentos online.
Logotipo de Google Docs

__._,_.___
Actividad reciente:
.

__,_._,___